RecruitingNot ApplicableNCT05815745

"Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment" (PROTECT-HF)

Physiological vs Right Ventricular Pacing Outcome Trial Evaluated for bradyCardia Treatment


Sponsor

Imperial College London

Enrollment

2,600 participants

Start Date

Jun 5, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The PROTECT-HF multi-centre randomised controlled trial will compare two different pacing approaches for treating patients with slow heart rates. In it the investigators will compare a long-standing standard approach for pacing; right ventricular pacing, with a new form of pacing, physiological pacing (His and Left bundle area pacing) in 2600 patients. Patients will be allocated at random to receive either right ventricular pacing or physiological pacing. Endpoint measurements will be undertaken at baseline, and at six-monthly intervals post-randomisation. Treatment allocation will be blinded to the endpoint assessor and the patient. Recruitment and pacemaker implantation will be carried out at each participating centre. The primary analysis will be intention to treat. The investigators will also perform an on-treatment analysis. 2048 patients are needed to detect the expected effect size with 85% power. A total of 2600 patients will be recruited to allow for patient drop-out and crossover. 500-patient sub-study will assess within patient, and between groups, echocardiographic changes over a 24-month period to try and improve mechanistic understanding of PICM (Pacing Induced Cardiomyopathy).


Eligibility

Min Age: 18 Years

Inclusion Criteria9

  • We will recruit patients who are referred for clinically indicated pacemaker implantation
  • \. Adults aged over 18 with left ventricular ejection fraction \>35% and one or more of the following guideline based ventricular pacing indications:
  • Permanent or intermittent 3rd degree AV block
  • Permanent or intermittent Mobitz type II AV block
  • First Degree AV block with a pacing indication
  • Slow chronic Atrial Fibrillation or Proposed AV node ablation
  • Bifascicular block with a pacing indication
  • Trifascicular block with a pacing indication
  • Wenckebach with a pacing indication

Exclusion Criteria4

  • Patients who are likely to only need occasional ventricular pacing, i.e. those with isolated sick sinus syndrome.
  • Pregnant women.
  • Unable to provide informed consent.
  • Those with comorbidity leading to a life expectancy \<1year.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPacemaker - Physiological pacing

The approach for physiological pacing will be either His bundle pacing or left bundle pacing at the operator's discretion. If both of these are not achieved biventricular pacing will be performed.

DEVICEPacemaker - Right Ventricular pacing

Right ventricular pacing (apical or septal lead locations as per the implanting physicians' normal practice).


Locations(45)

Beacon Hospital

Dublin, Ireland

Univerisity Medical Centre Ljubljana

Ljubljana, Slovenia

Aberdeen Royal Infirmary

Aberdeen, United Kingdom

Queen's Hospital

Barking, United Kingdom

Good Hope Hospital

Birmingham, United Kingdom

Queen Elizabeth Hospital

Birmingham, United Kingdom

University Hospital Dorset

Bournemouth, United Kingdom

Royal SUSSEX County Hospital

Brighton, United Kingdom

Bristol Heart Institute

Bristol, United Kingdom

Royal Papworth Hospital

Cambridge, United Kingdom

St Richard's Hospital

Chichester, United Kingdom

University Hospital Coventry

Coventry, United Kingdom

Croydon

Croydon, United Kingdom

Royal Infirmary of Edinburgh

Edinburgh, United Kingdom

Victoria Hospital

Fife Keith, United Kingdom

Medway Maritime Hospital

Gillingham, United Kingdom

Wycombe Hospital

High Wycombe, United Kingdom

Forth Valley Royal Hospital

Larbert, United Kingdom

Leeds Teaching Hospital

Leeds, United Kingdom

Glenfield Hospital

Leicester, United Kingdom

Liverpool Heart and Chest Hospital

Liverpool, United Kingdom

Hammersmith Hospital

London, United Kingdom

Kettering Hospital

London, United Kingdom

King's College Hospital

London, United Kingdom

Royal Free London/ Barnet Hospital

London, United Kingdom

St Bartholomew's Hospital

London, United Kingdom

Watford General Hospital

London, United Kingdom

James Cook Hospital

Middlesbrough, United Kingdom

King's Mill Hospital

Nottingham, United Kingdom

Nottingham City Hospital

Nottingham, United Kingdom

John Radcliffe Hospital

Oxford, United Kingdom

Derriford Hospital

Plymouth, United Kingdom

Queen Alexandra Hospital

Portsmouth, United Kingdom

Royal Berkshire

Reading, United Kingdom

East Surrey

Redhill, United Kingdom

Rotherham General Hospital

Rotherham, United Kingdom

Northern General

Sheffield, United Kingdom

Wexham Park Hospital

Slough, United Kingdom

Southampton

Southampton, United Kingdom

Morriston Hospital

Swansea, United Kingdom

Great Western

Swindon, United Kingdom

Musgrove Park Hospital

Taunton, United Kingdom

Torbay Hospital

Torquay, United Kingdom

UHS Worthing

Worthing, United Kingdom

York Hospital

York, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05815745


Related Trials